Windtree Therapeutics

$6.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+0.76%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell WINT and other stocks, options, and ETFs commission-free!

About WINT

Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Read More The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA. The listed name for WINT is Windtree Therapeutics, Inc. Common Stock.

Employees
32
Headquarters
Warrington, Pennsylvania
Founded
1992
Market Cap
91.36M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.03K
High Today
$6.76
Low Today
$6.62
Open Price
$6.63
Volume
7.89K
52 Week High
$10.06
52 Week Low
$5.00

Collections

WINT Earnings

-$3.24
-$2.16
-$1.08
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 12, After Hours

You May Also Like